Interspecies chimeras as a platform for exogenic organ production and transplantation

Daniel J Garry1,2,3,4, Mary G Garry1,2,3,4

  • 1Lillehei Heart Institute, University of Minnesota, Minneapolis, MN 55455, USA.

Insights

New therapeutic strategies are needed for chronic diseases. This review explores the potential of intraspecies and interspecies chimeras for organ transplantation, alongside scientific and ethical considerations.

Area of Science:

  • Regenerative Medicine
  • Transplantation Biology
  • Bioethics

Background:

  • Chronic diseases present significant global health challenges, leading to substantial morbidity and mortality.
  • Current therapeutic options for end-stage organ damage are limited, necessitating innovative approaches.

Purpose of the Study:

  • To review the scientific rationale and feasibility of generating intraspecies and interspecies chimeras.
  • To discuss the potential of chimera technology as a future platform for organ transplantation.
  • To highlight the associated scientific and ethical considerations.

Main Methods:

  • Review of existing scientific literature on chimera generation.
  • Analysis of the potential applications in organ transplantation.
  • Discussion of ethical frameworks and scientific challenges.

Main Results:

  • Intraspecies and interspecies chimeras show promise as a source for organ generation.
  • The development of chimera technology could offer a solution to organ shortages.
  • Significant scientific and ethical hurdles remain to be addressed.

Conclusions:

  • Chimera generation presents a novel, albeit complex, strategy for addressing the organ transplantation crisis.
  • Further research and ethical deliberation are crucial for the responsible advancement of this technology.